MIDDLE EAST AND AFRICA NASAL SPRAY MARKET 2021-2028

 

 TABLE OF CONTENTS

1.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1.    ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2.    UTILIZING NASAL SPRAY FOR DIABETES

2.2.3.    ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    CONTRACTS & AGREEMENTS

2.6.3.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2.    INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3.    GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1.    COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1.    APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2.    USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3.    EMPLOYING NASAL SPRAY AS A VACCINE

3.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8.     MIDDLE EAST AND AFRICA NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. UNITED ARAB EMIRATES

8.2. SAUDI ARABIA

8.3. TURKEY

8.4. SOUTH AFRICA

8.5. REST OF MIDDLE EAST & AFRICA

9.     COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10.               PFIZER INC

9.11.               PROCTOR AND GAMBLE CO

9.12.               SANOTIZE RESEARCH AND DEVELOPMENT

9.13.               SUN PHARMACEUTICALS INDUSTRIES LTD

9.14.               TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15.               VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1.               RESEARCH SCOPE & DELIVERABLES

10.2.               SOURCES OF DATA

10.3.               RESEARCH METHODOLOGY

 

 

TABLE LIST

 

TABLE 1: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

 

 

FIGURE LIST

 

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: UNITED ARAB EMIRATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: SAUDI ARABIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: TURKEY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: SOUTH AFRICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

 

Triton’s research report states that the Middle East and Africa’s nasal spray market is predicted to grow at a compound annual growth rate of 7.93% through the estimated years 2021-2028. Turkey, the UAE, South Africa, Saudi Arabia, and Rest of Middle East & Africa form the considered market in this region.

Cases relating to lung diseases have increased significantly in Turkey over the past few years. As per estimates, approximately five million people suffer from chronic obstructive pulmonary disease every year. Further, lower respiratory tract infections, including pneumonia, are responsible for a significant amount of children’s deaths in the country, according to the Turkish Thoracic Society. Other than this, asthma poses a considerable burden on the country’s medical sector. Hence, this surge in the incidence of respiratory diseases are key factors that are likely to fuel the growth of the nasal spray market in the near future within Turkey.

Similarly, asthma and chronic rhinosinusitis are among the highly prevalent conditions in South Africa. Additionally, the prevalence of allergic rhinitis and hay fever is also high among adolescents. Other than this, earlier, the country ranks 25^th globally for asthma prevalence and fifth for asthma mortality. This indicates the growing market for nasal sprays to treat various conditions. Therefore, as mentioned above, these factors are estimated to propel the South African nasal spray market on a positive growth trajectory over the estimated phase.

 

 

COMPETITIVE OUTLOOK

 

The renowned companies in the nasal spray market include Allergan, Catalent Inc, Cipla Limited, Pfizer Inc, Johnson and Johnson, Akorn, and Novartis International AG.

 

Get more insights into the Middle East & Africa Nasal Spray Market:

 

https://www.tritonmarketresearch.com/reports/middle-east-and-africa-nasal-spray-market

 

 

SEGMENTATION

 

1.     AKORN

2.     ALLERGAN

3.     APOTEX INC

4.     BHARAT BIOTECH

5.     CATALENT INC

6.     CIPLA LIMITED

7.     GLAXOSMITHKLINE

8.     JOHNSON AND JOHNSON

9.     NOVARTIS INTERNATIONAL AG

10. PFIZER INC

11. PROCTOR AND GAMBLE CO

12. SANOTIZE RESEARCH AND DEVELOPMENT

13. SUN PHARMACEUTICALS INDUSTRIES LTD

14. TEVA PHARMACEUTICAL INDUSTRIES LTD

15. VIATRIS